Brodalumab - AstraZeneca/Bausch Health Companies/Kyowa Kirin/LEO Pharma
Alternative Names: AMG-827; KHK-4827; Kyntheum; LP 0160; LUMICEF; SILIQ; SiliqLatest Information Update: 23 Aug 2024
At a glance
- Originator Amgen
- Developer Amgen; AstraZeneca; Bausch Health Companies; Kyowa Hakko Kirin; Kyowa Kirin; LEO Pharma
- Class Anti-inflammatories; Antiasthmatics; Antipsoriatics; Antirheumatics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 17 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Ankylosing spondylitis; Axial spondyloarthritis; Erythrodermic psoriasis; Palmoplantar pustulosis; Plaque psoriasis; Psoriasis; Psoriatic arthritis; Pustular psoriasis
- Preregistration Systemic scleroderma
- Discontinued Asthma; Crohn's disease; Rheumatoid arthritis